Article

Fiscal Year 2016 Funding Bill Seeks to Defund the ACA, Patient-Centered Outcomes Research

Author(s):

In its proposed fiscal year 2016 funding bill, the House Appropriations Committee is looking to defund the Affordable Care Act, block additional funding for patient-centered outcomes research, and terminate the Agency for Healthcare Research and Quality.

In its proposed fiscal year 2016 funding bill, the House Appropriations Committee is looking to defund the Affordable Care Act, block additional funding for patient-centered outcomes research, and terminate the Agency for Healthcare Research and Quality.

The draft bill reduces discretionary funding by $3.7 billion from fiscal year 2015 and is $14.6 billion below President Obama’s budget request.

“This legislation continues our efforts to reduce wasteful spending, to stop harmful and unnecessary regulations that kill jobs and impede economic growth, and to make wise investments in proven programs on behalf of the American taxpayer,” House Appropriations Chairman Hal Rogers said in a statement.

The bill rescinds $6.8 billion in funding for the Center for Medicare and Medicaid Innovation, and $100 million for the Patient-Centered Outcomes Research Trust, and will transfer $914.3 million from the Prevention and Public Health Fund to the Centers for Disease Control and Prevention.

However, under the draft bill, the National Institutes of Health would receive $31.2 billion, which is $1.1 billion above funding for fiscal year 2015.

Read more at Inside Health Policy: http://bit.ly/1CdZ8ZA

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Kenny Cole, MD
Joseph Saseen, PharmD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo